Pfizer's gene therapy for hemophilia treatment approved by Health Canada, company says January 03, 2024 Pfizer said on Wednesday that Canada's health regulator approved its gene therapy for the treatment of a rare inherited bleeding disorder called hemophilia B ahead of a U.S. decision. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.